The Board of Directors of the NanoMedicines Innovation Network (NMIN), a national Networks of Centres of Excellence (NCE) funded by the Government of Canada, has appointed Dr. Gilbert Walker Scientific Director & CEO, effective 14 September 2022. Dr. Walker is a Distinguished Professor in the Department of Chemistry in the… Read More »NMIN Board of Directors names Dr. Gilbert Walker Scientific Director & CEO
L to R: Yulin Mo, Dr. Miffy Cheng and Jerry Leung. NMIN is extremely proud to acknowledge the NMIN trainees who won all three of the Poster Awards granted at Liposome Research Days (LRD) 2022. Yulin Mo (University of Toronto), Dr. Miffy Cheng and Jerry Leung (both at The University… Read More »NMIN trainees win all three poster awards at LRD 2022
The NanoMedicines Innovation Network (NMIN) is pleased to announce the 15 recipients of the its 2022 Masters- and Doctoral-level Graduate Awards. Recipients hail from seven universities in five provinces. The goal of NMIN Graduate Awards is to enable exceptional students to pursue nanomedicine academic research training with Canadian experts. Doctoral… Read More »Meet the winners of NMIN’s 2022 Graduate Awards
Dr. Pieter Cullis continues to accumulate accolades for his life’s work developing liposomal-based technologies as the basis for novel therapeutic approaches to diagnosing, treating, and curing disease. An additional recognition, “for his scientific entrepreneurialism and advancement of life sciences research,” is coming in the form of the Global Impact Award… Read More »Pieter Cullis to receive Global Impact Award from Life Sciences BC
The start-up company SeraGene, spun out of NMIN and co-founded by NMIN research co-leader Dr. Christian Kastrup (UBC), NMIN HQP Amy Wong-Strilchuk, and NMIN’s Founding Scientific Director, Dr. Pieter Cullis, has received a 2022 “Amgen Golden Ticket” at the UBC-based SBME Innovates incubation hub. UBC’s School of Biomedical Engineering (SBME)… Read More »NMIN start-up SeraGene wins Amgen-sponsored incubation support
For their contributions to the development of an mRNA-based COVID vaccine, NMIN’s Founding Scientific Director, Dr. Pieter Cullis (UBC), together with his colleagues Drs Katalin Karikó (University of Szeged) and Drew Weissman (University of Pennsylvania), have been jointly awarded the 2022 Tang Prize in in Biopharmaceutical Science. The prize recognizes… Read More »Dr. Pieter Cullis & colleagues awarded 2022 Tang Prize
A new special issue of the American Chemical Society journal Molecular Pharmaceutics highlights outstanding work related to contemporary nanomedicine research in Canada. The issue, “Tiny Things, Huge Impact: Nanomedicine in Canada,” was edited by NMIN researchers Dr. Shyh-Dar Li, Ellen Wasan, Marcel Bally, and Sarah Hedtrich, who contribute an editorial summarizing the… Read More »Canadian nanomedicines in the spotlight: Molecular Pharmaceutics
The NanoMedicines Innovation Network (NMIN) is pleased to announce the eight recipients of the 2022 NMIN Undergraduate Studentships in NanoMedicines Research awards. The awardees will receive a stipend of $1,500 a month for a maximum of four months between May 2022 and March 2023, to work on a nanomedicines-related research… Read More »2022 NMIN Undergraduate Studentships awarded
https://youtu.be/4eg6Y8x1JXE?list=PLh7NyssbO61nky9vVCrRsJG9izYAl5VV6Video profile of GGIA Laureate Acuitas A research team assembled in UBC approximately 40 years ago by NMIN’s Founding Scientific Director, Dr. Pieter Cullis, is receiving a 2022 Governor General’s Innovation Award for their work in developing lipid nanoparticle (LNP) systems to deliver cancer drugs to tumours and to enable… Read More »NMIN’s Founding Scientific Director receives Governor General’s Innovation Award
NMIN spin-off company NanoVation Therapeutics™ (NTx) is growing rapidly and is expanding its overseas operations with the launch of its first NanoVation GENErator™ in the UK, based at the Harwell Science and Innovation Campus near Oxford. The Honourable François-Philippe Champagne PC, MP (Minister of Innovation, Science and Industry) visits NanoVation’s… Read More »NMIN spin-off company NanoVation Therapeutics is expanding into UK